HAE - Haemonetics Corp.
This page shows which of the focused investors we track hold HAE and how their positions changed, so you can see how much conviction the group has in the stock.
In Q3 2013 it was held by 2 managers with an aggregate reported value of $2.03M, which is 0.00% of the combined portfolio.
As of Q3 2013, 2 tracked institutional managers held HAE (Haemonetics Corp.) with an aggregate reported value of $2.03M — 0.00% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades HAE — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q3 2013
- Ticker
- HAE
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Third Avenue Management - Third Avenue Management | 0.03% | - | 42,000 | $1.68M |
| 2 | First Eagle - First Eagle Investment Management | 0.00% | - | 9,000 | $359K |
Loading holder history for HAE…